Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Goldman Sachs: Still bullish on gold, reaffirms target price of $5,400/ounce by the end of 2026. Its updated 12-month moving average forecast shows that central banks purchased 50 tons of gold per month in March, compared to the previous forecast of 29 tons per month. It is expected that central bank gold purchases will increase, with the average monthly purchase reaching 60 tons by 2026.

Goldman Sachs: Still bullish on gold, reaffirms target price of $5,400/ounce by the end of 2026. Its updated 12-month moving average forecast shows that central banks purchased 50 tons of gold per month in March, compared to the previous forecast of 29 tons per month. It is expected that central bank gold purchases will increase, with the average monthly purchase reaching 60 tons by 2026.

汇通财经汇通财经2026/05/15 23:43
Show original
Goldman Sachs: Still bullish on gold and reiterates its price target of $5,400/oz by the end of 2026. Its updated 12-month moving average forecast shows that central banks purchased 50 tons of gold per month in March, compared to the previous estimate of 29 tons per month. Central bank gold purchases are expected to increase, with the average monthly purchase reaching 60 tons by 2026.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)

A $2.4 billions debt financing round, led by funds under Blue Owl Capital Inc., has been finalized. The funds will be allocated to cloud service provider IREN Ltd. to purchase NVIDIA's Blackwell Ultra GPUs, supporting the development of its data center campus in Canada.

智通财经2026/08/29 02:27
Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)